Victor Ortiz-Soriano1, Shaowli Kabir2, Rolando Claure-Del Granado3, Arnold Stromberg2, Robert D Toto4, Orson W Moe4, Stuart L Goldstein5, Javier A Neyra1,4. 1. Department of Internal Medicine, Division of Nephrology, Bone and Mineral Metabolism, University of Kentucky Medical Center, Lexington, KY, USA. 2. Department of Statistics, University of Kentucky, Lexington, Kentucky, USA. 3. School of Medicine, Universidad Mayor San Simon, Cochabamba, Bolivia. 4. Department of Internal Medicine, Division of Nephrology, Charles and Jane Pak Center of Mineral Metabolism and Clinical Research, University of Texas Southwestern Medical Center, Dallas, TX, USA. 5. Center for Acute Care Nephrology, Cincinnati Children's Hospital and Medical Center, University of Cincinnati, Cincinnati, OH, USA.
Abstract
BACKGROUND: The renal angina index (RAI) is a useful tool for risk stratification of acute kidney injury (AKI) in critically ill children. We evaluated the performance of a modified adult RAI (mRAI) for the risk stratification of AKI in critically ill adults. METHODS: We used two independent intensive care unit (ICU) cohorts: 13 965 adult patients from the University of Kentucky (UKY) and 4789 from University of Texas Southwestern (UTSW). The mRAI included: diabetes, presence of sepsis, mechanical ventilation, pressor/inotrope use, percentage change in serum creatinine (SCr) in reference to admission SCr (ΔSCr) and fluid overload percentage within the first day of ICU admission. The primary outcome was AKI Stage ≥2 at Days 2-7. Performance and reclassification metrics were determined for the mRAI score compared with ΔSCr alone. RESULTS: The mRAI score outperformed ΔSCr and readjusted probabilities to predict AKI Stage ≥2 at Days 2-7: C-statistic: UKY 0.781 versus 0.708 [integrated discrimination improvement (IDI) 2.2%] and UTSW 0.766 versus 0.696 (IDI 1.8%) (P < 0.001 for both). In the UKY cohort, only 3.3% of patients with mRAI score <10 had the AKI event, while 16.4% of patients with mRAI score of ≥10 had the AKI event (negative predictive value 96.8%). Similar findings were observed in the UTSW cohort as part of external validation. CONCLUSIONS: In critically ill adults, the adult mRAI score determined within the first day of ICU admission outperformed changes in SCr for the prediction of AKI Stage ≥2 at Days 2-7 of ICU stay. The mRAI is a feasible tool for AKI risk stratification in adult patients in the ICU.
BACKGROUND: The renal angina index (RAI) is a useful tool for risk stratification of acute kidney injury (AKI) in critically ill children. We evaluated the performance of a modified adult RAI (mRAI) for the risk stratification of AKI in critically ill adults. METHODS: We used two independent intensive care unit (ICU) cohorts: 13 965 adult patients from the University of Kentucky (UKY) and 4789 from University of Texas Southwestern (UTSW). The mRAI included: diabetes, presence of sepsis, mechanical ventilation, pressor/inotrope use, percentage change in serum creatinine (SCr) in reference to admission SCr (ΔSCr) and fluid overload percentage within the first day of ICU admission. The primary outcome was AKI Stage ≥2 at Days 2-7. Performance and reclassification metrics were determined for the mRAI score compared with ΔSCr alone. RESULTS: The mRAI score outperformed ΔSCr and readjusted probabilities to predict AKI Stage ≥2 at Days 2-7: C-statistic: UKY 0.781 versus 0.708 [integrated discrimination improvement (IDI) 2.2%] and UTSW 0.766 versus 0.696 (IDI 1.8%) (P < 0.001 for both). In the UKY cohort, only 3.3% of patients with mRAI score <10 had the AKI event, while 16.4% of patients with mRAI score of ≥10 had the AKI event (negative predictive value 96.8%). Similar findings were observed in the UTSW cohort as part of external validation. CONCLUSIONS: In critically ill adults, the adult mRAI score determined within the first day of ICU admission outperformed changes in SCr for the prediction of AKI Stage ≥2 at Days 2-7 of ICU stay. The mRAI is a feasible tool for AKI risk stratification in adult patients in the ICU.
Authors: Sadudee Peerapornratana; Carlos L Manrique-Caballero; Hernando Gómez; John A Kellum Journal: Kidney Int Date: 2019-06-07 Impact factor: 10.612
Authors: Michael Heung; Diane E Steffick; Kara Zivin; Brenda W Gillespie; Tanushree Banerjee; Chi-Yuan Hsu; Neil R Powe; Meda E Pavkov; Desmond E Williams; Rajiv Saran; Vahakn B Shahinian Journal: Am J Kidney Dis Date: 2015-12-12 Impact factor: 8.860
Authors: Rajit K Basu; Michael Zappitelli; Lori Brunner; Yu Wang; Hector R Wong; Lakhmir S Chawla; Derek S Wheeler; Stuart L Goldstein Journal: Kidney Int Date: 2013-09-18 Impact factor: 10.612
Authors: Ayodele Odutayo; Christopher X Wong; Michael Farkouh; Douglas G Altman; Sally Hopewell; Connor A Emdin; Benjamin H Hunn Journal: J Am Soc Nephrol Date: 2016-06-13 Impact factor: 10.121
Authors: Henrik Gammelager; Christian Fynbo Christiansen; Martin Berg Johansen; Else Tønnesen; Bente Jespersen; Henrik Toft Sørensen Journal: Crit Care Date: 2014-10-14 Impact factor: 9.097
Authors: Javier A Neyra; Ming-Chang Hu; Abu Minhajuddin; Geoffrey E Nelson; Syed A Ahsan; Robert D Toto; Michael E Jessen; Orson W Moe; Amanda A Fox Journal: Kidney Int Rep Date: 2019-05-18
Authors: Danielle E Soranno; Azra Bihorac; Stuart L Goldstein; Kianoush B Kashani; Shina Menon; Girish N Nadkarni; Javier A Neyra; Neesh I Pannu; Karandeep Singh; Jorge Cerda; Jay L Koyner Journal: Kidney360 Date: 2021-11-18
Authors: Stuart L Goldstein; Kelli A Krallman; Cassie Kirby; Jean-Philippe Roy; Michaela Collins; Kaylee Fox; Alexandra Schmerge; Sarah Wilder; Bradley Gerhardt; Ranjit Chima; Rajit K Basu; Lakhmir Chawla; Lin Fei Journal: Kidney Int Rep Date: 2022-05-25